<DOC>
	<DOCNO>NCT01932502</DOCNO>
	<brief_summary>The purpose study examine clinical safety , tolerability , efficacy clobazam ( Onfi ) replace pre-existing clonazepam therapy patient refractory epilepsy .</brief_summary>
	<brief_title>Evaluation Onfi Conversion Therapy Replacing Clonazepam Patients With Medically Refractory Epilepsy</brief_title>
	<detailed_description>The study design answer frequently ask question clinician replace exist 1,4-benzodiazepine Onfi , follow : 1 . What optimal equivalent dos conversion ? 2 . How quickly convert ? 3 . Would significant improvement seizure control ? 4 . Should expect difference tolerability ? If , common adverse event ? 5 . Would tolerance therapeutic effect differ Onfi conversion ?</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<mesh_term>Clobazam</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>Subject confirm diagnosis medically refractory epilepsy without secondary generalization least 12 month prior initial study visit . Currently take stable dose regimen clonazepam ( 0.54mg daily ) seizure control . Takes least one additional Antiepileptic drug besides benzodiazepine . Age 1870 year , inclusive . In opinion investigator , safely treat Onfi . Minimum 2 seizure , 24 complex partial generalize seizure , 8week baseline period prior study entry . Able communicate effectively study personnel consider reliable , able , willing , cooperative regard complying protocoldefined requirement , include completion study diary . Clinically relevant current illness history may interfere subject 's ability complete study determine investigator . History status epilepticus within 6 month prior initial study visit . History suicidal attempt suicidal ideation within 12 month initial visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>Onfi</keyword>
	<keyword>clonazepam</keyword>
</DOC>